Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-16 · accession 0001683168-23-005828 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-16 | 2023-08-16 | CNSP | Climaco John M | CEO, Dir | P - Purchase | $1.80 | +2,750 | 49.0K | +6% | +$4,950 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | P | A | 2,750 | $1.80 | 49,010 | D | — | — |